1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
(
- Contribution to journal › Article
- 2019
-
Mark
How is alpha-synuclein cleared from the cell?
(
- Contribution to journal › Scientific review
-
Mark
Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates
(
- Contribution to journal › Article
- 2018
-
Mark
In vivo quantification of glial activation in minipigs overexpressing human α-synuclein
(
- Contribution to journal › Article
- 2016
-
Mark
A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
(
- Contribution to journal › Article
- 2013
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
(
- Contribution to journal › Article
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
(
- Contribution to journal › Scientific review
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
(
- Contribution to journal › Article